Clinical Trials for SURGE Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: SURGE Therapeutics

Clinical Trials (4)

NCT06450106
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
PHASE1Recruiting
18 participants
Started: May 8, 2025 · Completed: Mar 31, 2026
1 condition1 sponsor4 locations
NCT06300411
SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery
PHASE1Recruiting
24 participants
Started: Jul 29, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor8 locations
NCT06136819
RT-310 Dose Escalation BPH Study
PHASE1Recruiting
20 participants
Started: Apr 19, 2024 · Completed: Dec 31, 2027
2 conditions1 sponsor4 locations
NCT05710848
A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
PHASE1/PHASE2Recruiting
75 participants
Started: Jul 11, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor10 locations